$SEARL The Searle Company Limited (SEARL): Result Review – By Taurus Research
$SEARL
The Searle Company Limited
Rs. 90.42
-1.16%
- 1QFY26: – EPS: PKR 0.58, PAT: PKR 298Mn, down 30%YoY over the SPLY.
- In 1QFY26, top-line is expected to arrive at PKR 7.2Bn as compared to PKR 7.6Bn, down 5%YoY. Whereas, expected to increase 9%QoQ mainly due to the seasonal shift, favorable sales mix and deregulation of non-essential drugs. Gross margins are expected to increase 3pptsYoY driven by higher prices of medicines following deregulation. However, administrative expenses are likely to surge on the back of higher costs amid plans for launch of new products.